| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $78.9M | +13.9% | +9.2% |
| SG&A Expense | $11.4M | -2.3% | +19.9% |
| Operating Income | -$90.2M | -11.6% | -10.4% |
| Interest Expense | $1.1M | -6.8% | -12.4% |
| Net Income | -$81.6M | -15.7% | -12.2% |
| EPS (Basic) | -$0.99 | -15.1% | +5.7% |
| EPS (Diluted) | -$0.99 | -15.1% | +5.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $176.0M | -20.1% | -44.3% |
| Short-term Investments | $561.8M | +7.7% | +40.0% |
| Current Assets | $754.5M | -1.3% | +1.0% |
| Total Assets | $1.01B | -9.3% | +23.0% |
| Current Liabilities | $47.7M | -21.1% | +10.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$183.1M | — | — |
| Investing Cash Flow | -$346.1M | — | — |
| Financing Cash Flow | $364.9M | — | — |
| $47.9M |
| -42.5% |
| -39.5% |
| Stockholders' Equity | $957.6M | -6.6% | +29.7% |